Show simple item record

dc.contributor.authorMaloney, Ann E.
dc.contributor.authorYakutis, Lauren J.
dc.contributor.authorFrazier, Jean A.
dc.date2022-08-11T08:10:28.000
dc.date.accessioned2022-08-23T17:10:23Z
dc.date.available2022-08-23T17:10:23Z
dc.date.issued2012-10-01
dc.date.submitted2012-12-10
dc.identifier.citationChild Adolesc Psychiatr Clin N Am. 2012 Oct;21(4):885-909. doi: 10.1016/j.chc.2012.07.011. <a href="http://dx.doi.org/10.1016/j.chc.2012.07.011" target="_blank">Link to article on publisher's site</a>
dc.identifier.issn1056-4993 (Linking)
dc.identifier.doi10.1016/j.chc.2012.07.011
dc.identifier.pmid23040906
dc.identifier.urihttp://hdl.handle.net/20.500.14038/46035
dc.description.abstractPsychotic symptoms presenting in youth can be clinically complex and require that a child and adolescent psychiatrist use significant skill in making a diagnosis and initiating treatment. There are a number of illnesses to rule out before making a diagnosis of early-onset schizophrenia in particular. Psychosis in youth has significant associated morbidity and places high demands not only on families but also on the medical and educational systems. More effective pharmacologic and nonpharmacologic treatments for psychosis are needed. Nonpharmacologic therapies targeting relatively treatment-resistant domains of dysfunction such as neurocognition are also necessary as adjunctive treatments to our extant pharmacologic agents.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=23040906&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1016/j.chc.2012.07.011
dc.subjectAntipsychotic Agents
dc.subjectPsychotic Disorders
dc.subjectSchizophrenia
dc.subjectMedical Pharmacology
dc.subjectMental and Social Health
dc.subjectPsychiatry
dc.subjectPsychiatry and Psychology
dc.titleEmpirical evidence for psychopharmacologic treatment in early-onset psychosis and schizophrenia
dc.typeJournal Article
dc.source.journaltitleChild and adolescent psychiatric clinics of North America
dc.source.volume21
dc.source.issue4
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/psych_pp/564
dc.identifier.contextkey3523829
html.description.abstract<p>Psychotic symptoms presenting in youth can be clinically complex and require that a child and adolescent psychiatrist use significant skill in making a diagnosis and initiating treatment. There are a number of illnesses to rule out before making a diagnosis of early-onset schizophrenia in particular. Psychosis in youth has significant associated morbidity and places high demands not only on families but also on the medical and educational systems. More effective pharmacologic and nonpharmacologic treatments for psychosis are needed. Nonpharmacologic therapies targeting relatively treatment-resistant domains of dysfunction such as neurocognition are also necessary as adjunctive treatments to our extant pharmacologic agents.</p>
dc.identifier.submissionpathpsych_pp/564
dc.contributor.departmentDepartment of Psychiatry
dc.source.pages885-909


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record